Granted Patent B2

US 12,350,179 · App. 18/241,151 · Granted Jul 8, 2025

Inventors: Mark C. Brister (Encinitas, CA); Paul D. Faucher (Escondido, CA); Neil R. Drake (San Diego, CA); Andrew P. Rasdal (San Diego, CA); Matthew S. Lake (Carlsbad, CA); Dubravka Markovic (San Diego, CA); Amy D. L. VandenBerg (San Diego, CA); Antonio C. Llevares (Chula Vista, CA); Josefina Nider (San Diego, CA)

Assignee: RESHAPE LIFESCIENCES INC.

A61F5/003A61F5/0036A61F5/0089A61M25/10181A61M29/02A61M25/10185

Abstract

Claims (25)

1. An intragastric balloon system, comprising:

a capsule configured to be swallowable by a patient by normal peristalsis and to degrade in a gastric environment;

a balloon compacted and contained within the capsule, the balloon including an outer surface, an inner surface, an interior cavity, a fill valve, and a release valve, wherein the fill valve and the release valve are separate valves;

a catheter configured to be coupled to the fill valve, wherein

after the patient swallows the capsule, a first portion of the catheter is configured to remain outside the patient's mouth and a second portion of the catheter is configured to remain in the patient while the catheter is coupled to the fill valve,

the catheter is further configured to deliver a saline liquid through the fill valve to the interior cavity of the balloon for inflating the balloon with the saline liquid when the balloon is in the patient's stomach, and

the catheter is further configured to be detached from the fill valve after inflating the balloon with the saline liquid;

wherein the fill valve is a self-sealing valve that is configured to self-seal after the catheter is detached from the fill valve;

wherein at least a degradable portion of the release valve is configured to degrade in an internal environment of the interior cavity of the balloon when the saline liquid is in the interior cavity of the balloon and in response to the saline liquid being in contact with the degradable portion of the release valve;

wherein when the saline liquid is in the interior cavity of the balloon, the degradable portion of the release valve is configured to be degraded by contact with the saline liquid such that the degradation process opens the release valve to allow the saline liquid to travel from the interior cavity of the balloon into the gastric environment thereby deflating the balloon; and

wherein the release valve comprises a moisture absorbing expandable portion.

2. The intragastric balloon system of claim 1 , wherein the degradable portion of the release valve is configured to degrade in the internal environment of the interior cavity of the balloon and thereby open the release valve at approximately between 1 month and 6 months after inflating the balloon with the saline liquid.

3. The intragastric balloon system of claim 1 , wherein the degradable portion of the release valve is configured to degrade in the internal environment of the interior cavity of the balloon and thereby open the release valve at approximately 3 months after inflating the balloon with the saline liquid.

4. The intragastric balloon system of claim 1 , wherein the deflated balloon is configured to pass through a remainder of the patient's digestive tract.

5. The intragastric balloon system of claim 1 , further comprising a liquid container configured to couple to the catheter and supply the saline liquid to the catheter for inflating the balloon.

6. The intragastric balloon system of claim 1 , wherein the catheter is configured to be detached from the fill valve of the balloon after the balloon is filled or inflated with the saline liquid by pulling back the first portion or the second portion of the catheter.

7. The intragastric balloon system of claim 1 , wherein at approximately between 1 month and 6 months after inflating the balloon with the saline liquid, the degradable portion of the release valve is configured to degrade and allow the saline liquid to drain from the interior cavity of the balloon.

8. The intragastric balloon system of claim 1 , wherein the balloon is configured to transit a gastrointestinal tract and be excreted after the balloon is deflated.

9. The intragastric balloon system of claim 1 , wherein the interior cavity is defined by the inner surface of the balloon.

10. The intragastric balloon system of claim 1 , wherein the release valve comprises an erodible core.

11. The intragastric balloon system of claim 1 , wherein the release valve comprises a degradable patch.

12. The intragastric balloon system of claim 1 , wherein the outer surface of the balloon separates the gastric environment from the release valve.

13. The intragastric balloon system of claim 1 , wherein the compacted balloon is configured to contain no liquid before the patient swallows the capsule.

14. The intragastric balloon system of claim 1 , further comprising the saline liquid.

15. The intragastric balloon system of claim 1 , wherein the release valve includes an erodible seam.

Assignments (3)

Continuity (8)

References Cited (250)